Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant

NCT02240381 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped Funding expired

Conditions

Diabetes Mellitus
Malignant Neoplasm

Interventions

PROCEDURE: assessment of therapy complications
PROCEDURE: assessment of therapy complications
OTHER: laboratory biomarker analysis

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]